Skip to main content

Cancer Australia Publications

Review Use of luteinising hormone-releasing agonists adjuvant treatment early breast cancer

A systematic review to summarise current evidence about the role of LHRH agonists in the adjuvant treatment of ER+ early breast cancer in pre-menopausal women, with a view to providing evidence to support the information needs of women with breast cancer, clinicians, media and policy makers.

This resource has been superseded in-full or in-part by Review Use of taxanes for neo and adjuvant treatment early and locally advanced breast cancer.

File name: lha-1-use-of-luteinising-ho...juvant-treatment-of-ebc.pdf
File size: 399.83 KB
Cancer Type: Breast cancer
Publication Audience: Resources for health professionals
Year: 2003
Document Status: Greater than 5 years

This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.